AmnioBand® Viable Membrane
AmnioBand® Viable Membrane is an aseptically processed and cryopreserved human amnion membrane for use as an acute or chronic wound covering.
• Maintains inherent growth factors, matrix proteins, and endogenous viable cells shown to support host tissue remodeling
• Can be used for a wide array of acute and chronic wounds
• Rigorous screening and testing process
• Available in multiple sizes
• Two year shelf life
• Conforms to anatomy and maintains surface contact
• Each lot tested for cell viability using a metabolic assay before releasing for distribution
AmnioBand® Viable Membrane is a cryopreserved human allograft that is minimally processed to retain its inherent extracellular matrix components as well as a viable population of endogenous, adherent progenitor cells. AmnioBand® Viable is intended to be used as a protective covering for internal and external tissue defects including acute, chronic and surgically created wounds. It is intended for single use only.
The presence of severe vascular compromise, active or latent infection, or uncontrolled infection at the wound site may compromise the usefulness of the tissue.
Do not sterilize. Prescription use only. Trace amounts of vancyomycin, amphotericin B, gentamicin, and dimethyl sulfoxide (DMSO 10%) may be present. Caution should be exercised if the patient is allergic to any of these substances. NOTE: No beta-lactam antibiotics are used during the processing of tissue.
Do not use if packaging seal is damaged or not intact, if packaging has physical damage, if label or identifying bar code is severely damaged and illegible, if expiration date has passed, if allograft is received thawed, if not used within 1 hour after thawing, and if stored at a temperature not recommended.
Extensive medical screening procedures have been used in the selection of all tissue donors for MTF (please see Donor Screening and Testing of product insert). Transmission of infectious diseases such as HIV or hepatitis, as well as a theoretical risk of the Creutzfeld-Jakob (CJD) agent, may occur in spite of careful donor selection and serological testing.
Possible adverse effects of using human tissue include but are not limited to: infection, fever, disease transmission and undesirable human response, loss of function and/or integrity of the allograft due to resorption, fragmentation, and/or disintegration.
Store at or below -70°C.
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns||●|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Peel open the chevron end of the outer pouch and pass the inner film pouch into the sterile field. Place the sealed inner pouch containing the allograft and cryopreservation solution in a sterile basin containing room temperature sterile water or irrigant (i.e. normal saline or 5% dextrose in lactated Ringer’s solution) to thaw. Ensure that there is enough liquid to keep the pouch fully submerged. Note: the cryopreservation solution will turn to a reddish hue as it thaws. The pouch should be thawed in this basin until no ice crystals are visible, approximately 3-4 minutes. Do not thaw for more than 15 minutes. Carefully peel open the chevron end of the inner pouch. Transfer the plastic retainer containing the allograft into a sterile basin containing room temperature 5% dextrose in lactated Ringer’s solution. Ensure that there is enough liquid to keep the retainer fully submerged. Discard the inner pouch and cryopreservation solution. Keep the retainer in the basin for at least 5 minutes. The allograft can be kept in this basin for up to 1 hour. The allograft should be used within 1 hour of thawing. Remove plastic retainer from the basin and open the retainer. Using sterile forceps, remove the allograft from the plastic retainer. The allograft is provided on a white plastic backing with the stromal side facing the backing. Do not implant the backing.
AmnioBand® Viable Membrane should be changed weekly or as needed.
Primary Dressing: AmnioBand® Viable Membrane should be covered with a non-adherent dressing.
Secondary Dressing: AmnioBand® Viable Membrane requires a moist wound environment. Use appropriate moisture management dressings for the wound type and treatment ideology. To further encourage healing, patient should be appropriately offloaded following each visit as per institution's standard protocols.
MTF Biologics Wound Care is a division of MTF Biologics, the nation's leading non-profit tissue bank. The Wound Care division is dedicated to developing highly advanced, safe, clinically-based, and cost-effective wound care solutions that work in concert with the body's natural healing process.